analysi
therapeut
target
discoveri
potenti
drug
comput
method
acta
pharmaceutica
sinica
b
http
doi
twenti
structur
includ
target
human
target
built
homolog
model
librari
zinc
drug
databas
natur
product
antivir
drug
screen
target
plu
human
studi
provid
drug
reposit
candid
target
vitro
vivo
studi
mengzhu
zheng
xingzhouli
aliyuncom
xingzhou
li
author
made
equal
contribut
work
abstract
caus
ten
thousand
infect
one
thousand
death
current
regist
therapi
treat
coronaviru
infect
time
consum
process
new
drug
develop
drug
reposit
may
solut
epidem
sudden
infecti
diseas
systemat
analyz
protein
encod
gene
compar
protein
coronavirus
predict
structur
built
structur
could
done
homolog
model
perform
targetbas
virtual
ligand
screen
total
target
includ
two
human
target
screen
compound
librari
includ
zinc
drug
databas
databas
natur
product
structur
screen
result
import
target
proteas
spike
rnadepend
rna
polymeras
rdrp
papain
like
proteas
plpro
discuss
detail
addit
databas
commonli
use
antivir
drug
includ
current
market
undergo
clinic
trial
construct
possibl
target
compound
potenti
drug
act
certain
target
predict
studi
provid
new
lead
compound
target
vitro
vivo
studi
new
insight
drug
current
ongo
clinic
studi
also
possibl
new
strategi
drug
reposit
treat
infect
coronavirus
cov
caus
major
outbreak
human
fatal
pneumonia
sinc
begin
centuri
sever
acut
respiratori
syndrom
coronaviru
sarscov
broke
spread
five
contin
lethal
rate
merscov
broke
arabian
peninsula
fatal
rate
sarscov
merscov
zoonot
virus
host
batcivet
dromedari
respect
date
specif
therapeut
drug
vaccin
approv
treatment
human
coronaviru
therefor
cov
consid
kind
virus
outbreak
pose
huge
threat
human
wuhan
viral
pneumonia
case
discov
end
coronaviru
name
novel
coronaviru
world
health
organ
januari
sinc
highli
homolog
sarscov
consid
close
rel
sarscov
intern
viru
classif
commiss
ictv
classifi
sever
acut
respiratori
syndrom
coronaviru
februari
time
name
diseas
caus
common
symptom
person
infect
coronaviru
includ
respiratori
symptom
fever
cough
short
breath
dyspnea
sever
case
infect
caus
pneumonia
sever
acut
respiratori
syndrom
kidney
failur
even
death
current
specif
medicin
treatment
diseas
caus
cov
envelop
virus
posit
rna
genom
belong
coronavirida
famili
order
nidoviral
divid
four
genera
belong
genu
cov
contain
least
four
structur
protein
spike
protein
envelop
e
protein
membran
protein
nucleocapsid
n
protein
among
spike
promot
host
attach
viruscel
membran
fusion
viru
infect
therefor
spike
determin
extent
host
rang
potenti
anticoronaviru
therapi
divid
two
categori
depend
target
one
act
human
immun
system
human
cell
coronaviru
term
human
immun
system
innat
immun
system
respons
play
import
role
control
replic
infect
coronaviru
interferon
expect
enhanc
immun
respons
block
signal
pathway
human
cell
requir
viru
replic
may
show
certain
antivir
effect
addit
virus
often
bind
receptor
protein
surfac
cell
order
enter
human
cell
exampl
sar
viru
bind
angiotensinconvert
enzym
receptor
mer
bind
receptor
therapi
act
coronaviru
includ
prevent
synthesi
viral
rna
act
genet
materi
viru
inhibit
viru
replic
act
critic
enzym
viru
block
viru
bind
human
cell
receptor
inhibit
viru
selfassembl
process
act
structur
protein
fight
coronaviru
scientist
come
three
strategi
develop
new
drug
first
strategi
test
exist
broadspectrum
antivir
interferon
ribavirin
cyclophilin
inhibitor
use
treat
coronaviru
pneumonia
fall
categori
advantag
therapi
metabol
characterist
dosag
use
potenti
efficaci
side
effect
clear
approv
treat
viral
infect
disadvantag
therapi
broadspectrum
kill
coronavirus
target
manner
side
effect
underestim
second
strategi
use
exist
molecular
databas
screen
molecul
may
therapeut
effect
coronaviru
highthroughput
screen
make
strategi
possibl
new
function
mani
drug
molecul
found
strategi
exampl
discoveri
antihiv
infect
drug
lopinavirritonavir
third
strategi
directli
base
genom
inform
patholog
characterist
differ
coronavirus
develop
new
target
drug
scratch
theoret
drug
found
therapi
would
exhibit
better
anticoronaviru
effect
research
procedur
new
drug
might
cost
sever
year
even
year
develop
medicin
treat
fastest
way
find
potenti
molecul
market
drug
efficaci
determin
approv
green
channel
approv
hospit
ethic
committe
rapid
clinic
treatment
patient
herein
bioinformat
analysi
protein
encod
novel
coronaviru
gene
systemat
conduct
protein
compar
coronavirus
sarscov
merscov
conduct
homolog
model
build
possibl
protein
structur
includ
viral
papain
like
proteas
plpro
main
proteas
also
name
proteas
rnadepend
rna
polymeras
rdrp
helicas
spike
etc
use
protein
human
rel
protein
human
typeii
transmembran
serin
proteas
enzym
target
screen
zinc
u
food
drug
administr
fda
approv
drug
databas
zinc
drug
databas
zdd
databas
tradit
chines
medicin
natur
product
includ
report
common
antivir
compon
tradit
chines
medicin
databas
commonli
use
antivir
drug
compound
virtual
ligand
screen
method
studi
predict
varieti
compound
may
inhibit
novel
coronavirus
provid
scientist
inform
compound
may
effect
subsequ
valid
antivir
effect
vitro
vivo
provid
use
inform
clinic
treatment
novel
coronaviru
pneumonia
complet
genom
download
ncbi
nucleotid
databas
nucleotid
sequenc
align
whole
databas
use
blastn
search
homolog
viral
genom
alogorithm
paramet
max
target
sequenc
expect
threshold
obtain
genom
gene
bank
genom
sequenc
align
whole
databas
use
blastn
search
homolog
viral
genom
phylogenet
analysi
sequenc
align
coronavirus
variou
speci
found
three
coronavirus
bat
batcov
respect
highest
genom
sequenc
ident
fig
moreov
shown
fig
helicas
new
coronaviru
structur
biolog
studi
protein
still
earli
stage
one
crystal
structur
deposit
pdb
pdb
code
order
acquir
threedimension
structur
inform
protein
new
coronavirus
subsequ
drug
screen
align
protein
sequenc
sequenc
databas
fold
function
assign
system
support
inform
fig
fortun
protein
found
high
homolog
protein
threedimension
structur
homolog
support
inform
tabl
pdb
code
label
correspond
sequenc
fig
unsurprisingli
protein
highest
homolog
sar
nevertheless
protein
still
high
homolog
databas
predict
transmembran
helic
protein
carri
tmhmm
server
expect
found
protein
transmembran
protein
except
support
inform
fig
far
found
much
structur
inform
viral
protein
possibl
provid
basi
subsequ
homolog
model
drug
screen
homolog
model
protein
sequenc
align
model
sequenc
deriv
sarscov
predict
secondari
structur
time
fig
tabl
interestingli
shown
fig
import
antiviru
drug
target
protein
like
plpro
rdrp
highli
conserv
two
human
coronavirus
especi
function
region
shown
tabl
potenti
drug
target
protein
homolog
model
gener
protein
model
provid
pdb
file
support
inform
coordin
targetscreen
hit
complex
provid
upon
request
order
verifi
accuraci
homolog
model
align
comput
structur
model
sarscov
crystal
structur
solv
releas
manuscript
prepar
sequenc
sarscov
fig
recent
research
specul
could
also
bind
verifi
comput
dock
elisa
measur
moreov
homolog
spikerbd
sequenc
batcov
high
despit
high
homolog
spike
sequenc
analysi
found
four
among
five
import
amino
acid
bind
batcov
differ
fig
relat
research
literatur
whether
batcov
infect
human
yet
also
perform
homolog
model
batcov
spike
rbd
support
inform
fig
three
spike
rbd
structur
dock
human
among
conform
resembl
crystal
structur
sar
complex
bind
free
energi
spike
rbd
human
kcalmol
support
inform
fig
sarscov
spike
rbd
kcalmol
support
inform
fig
batcov
spike
rbd
kcalmol
support
inform
fig
therapi
act
coronaviru
divid
sever
categori
base
specif
pathway
act
enzym
function
protein
critic
viru
prevent
viru
rna
synthesi
replic
act
structur
protein
viru
block
viru
bind
human
cell
receptor
inhibit
viru
selfassembl
process
produc
virul
factor
restor
host
innat
immun
act
host
specif
receptor
enzym
prevent
viru
enter
host
cell
relat
target
protein
includ
plpro
base
homolog
model
viral
protein
model
human
target
resort
structurebas
virtual
ligand
screen
method
use
icm
model
softwar
molsoft
llc
screen
potenti
smallmolecul
compound
zinc
drug
databas
compound
small
inhous
databas
tradit
chines
medicin
natur
product
includ
report
common
antivir
compon
tradit
chines
medicin
deriv
compound
compound
lower
calcul
bind
energi
express
score
mfscore
consid
higher
bind
affin
target
protein
plpro
respons
cleavag
nterminu
replicas
polyprotein
releas
essenti
correct
viru
replic
plpro
also
confirm
signific
antagon
host
innat
immun
indispens
enzym
process
coronaviru
replic
infect
host
plpro
popular
target
coronaviru
inhibitor
valuabl
target
plpro
treat
coronaviru
infect
inhibitor
approv
fda
market
screen
result
tabl
antivir
drug
ribavirin
predict
bind
plpro
low
bind
energi
gener
dock
model
ribavirin
bound
activ
site
enzym
report
sarsplpro
inhibitor
pdb
code
hydrogen
bond
predict
compound
also
stack
found
triazol
compound
fig
b
strong
hydrogen
bond
hydrophob
interact
ribavirin
enzym
impli
may
potent
plpro
inhibitor
also
known
first
automat
cleav
polyprotein
produc
matur
enzym
cleav
downstream
nsp
site
releas
directli
mediat
matur
nsp
essenti
life
cycl
viru
detail
investig
structur
catalyt
mechan
make
attract
target
anticoronaviru
drug
develop
inhibitor
target
sarscov
mainli
includ
peptid
inhibitor
smallmolecul
inhibitor
monom
three
domain
domain
residu
domain
ii
residu
domain
iii
residu
long
loop
residu
connect
domain
ii
iii
activ
site
locat
gap
domain
ii
cyshi
catalyt
dyad
shown
tabl
support
excel
file
antibacteri
drug
lymecyclin
demeclocyclin
doxycyclin
oxytetracyclin
antihypertens
drug
nicardipin
telmisartan
conivaptan
treat
hyponatremia
show
highest
bind
affin
sever
natur
compound
deriv
antiviru
antiinflammatori
effect
also
exhibit
high
bind
affin
tabl
support
excel
file
includ
seri
andrographolid
deriv
scutellaria
baicalensi
betulon
cassin
xylocarpa
acid
isodecortinol
cerevisterol
viola
diffusa
hesperidin
neohesperidin
citru
aurantium
kouitchensid
deacetylcentapicrin
plant
swertia
genu
result
suggest
smallmolecul
compound
might
potenti
inhibitor
could
probabl
use
treat
worth
mention
antiasthmat
drug
montelukast
also
show
low
bind
energi
shown
fig
montelukast
well
fit
activ
pocket
lot
hydrophob
amino
acid
like
compos
rel
hydrophob
environ
contain
compound
stabil
conform
hydrogen
bond
predict
carbonyl
group
compound
fig
dna
rna
along
direct
ntpdepend
manner
importantli
report
sequenc
conserv
indispens
necessari
compon
replic
coronaviru
therefor
identifi
target
antivir
drug
discoveri
report
inhibitor
base
structur
model
helicas
protein
antibacteri
drug
lymecyclin
cefsulodin
rolitetracyclin
antifung
drug
itraconazol
antihuman
immunodefici
drug
saquinavir
anticoagul
drug
dabigatran
diuret
drug
canreno
acid
predict
helicas
inhibitor
high
mfscore
virtual
ligand
screen
natur
product
mani
flavanoid
differ
sourc
hesperidin
hesperidin
rutin
quercetagetin
homovitexin
show
high
bind
affin
target
besid
target
nonstructur
protein
includ
complex
also
play
import
role
viru
rna
synthesi
replic
suggest
protein
may
use
target
antivir
drug
discoveri
virtual
screen
result
show
mani
antibacteri
antivir
antiinflammatori
drug
zinc
drug
databas
inhous
natur
productsderiv
databas
display
potenti
good
affin
target
detail
inform
virtual
screen
result
shown
support
excel
file
zdd
screen
result
file
name
targetxlsx
natur
product
screen
result
file
name
targetnpxlsx
spike
main
structur
protein
coronaviru
assembl
special
corolla
structur
surfac
viru
trimer
spike
main
protein
interact
host
bind
host
cell
receptor
mediat
viru
invas
determin
viral
tissu
host
tropism
spike
cleav
host
cell
proteas
like
etc
main
function
bind
host
cell
surfac
receptor
howev
compound
predict
bind
bind
interfac
complex
compound
could
target
bind
interfac
spike
hesperidin
shown
fig
hesperidin
predict
lie
middl
shallow
pit
surfac
rbd
spike
dihydroflavon
part
compound
went
parallel
sheet
rbd
sugar
part
insert
shallow
pit
direct
away
hydrophob
amino
acid
includ
form
rel
hydrophob
shallow
pocket
contain
compound
fig
hydrogen
bond
predict
compound
superimpos
complex
hesperidinrbd
complex
distinct
overlap
hesperidin
interfac
could
observ
fig
suggest
hesperidin
may
disrupt
interact
rbd
except
spike
protein
e
protein
echannel
possess
import
biolog
function
structur
integr
coronaviru
host
virul
nrbd
crbd
coronaviru
n
protein
need
n
protein
host
cell
bind
coronaviru
rna
effici
therefor
e
protein
n
protein
nrbd
crbd
domain
use
target
discoveri
antivir
drug
virtual
screen
mani
antibacteri
antivir
antitumor
antiasthmat
antiinflammatori
drug
etc
zinc
databas
inhous
natur
productsderiv
databas
found
display
rel
good
affin
target
detail
result
virtual
screen
given
supplementari
excel
file
three
coronaviru
virul
factor
relat
interf
host
innat
immun
assist
coronaviru
immun
escap
interact
host
ribosom
subunit
induc
specif
host
mrna
degrad
also
inhibit
typei
interferon
product
abil
bind
host
adpribos
help
coronaviru
resist
host
innat
immun
bone
marrow
matrix
antigen
inhibit
releas
newlyassembl
coronaviru
host
cell
sarscov
directli
bind
inhibit
activ
block
glycosyl
evid
suggest
may
potenti
target
antivir
drug
discoveri
detail
screen
result
show
seri
clinic
drug
natur
product
antibacteri
antiinflammatori
effect
exhibit
rel
high
bind
affin
three
target
protein
piperacillin
cefpiramid
streptomycin
lymecyclin
tetracyclin
platycodin
platycodon
grandiflora
wogonosid
scutellaria
baicalensi
vitexin
vitex
negundo
andrographolid
deriv
xanthon
swertia
genu
detail
result
virtual
screen
shown
support
excel
file
host
prove
mani
studi
specif
receptor
spike
rbd
sarscov
latest
research
show
host
receptor
consist
sarscov
exhibit
spike
rbd
sequenc
similar
sarscov
rbd
import
interact
sever
key
amino
acid
residu
rbd
receptorbind
motif
base
current
research
progress
consid
host
target
treatment
coronaviru
infect
block
enter
host
cell
base
virtual
screen
result
protein
antidiabet
drug
troglitazon
antihypertens
drug
losartan
analgesia
drug
ergotamin
antibacteri
drug
cefmenoxim
hepatoprotect
drug
silybin
etc
predict
bind
low
energi
natur
product
phyllaemblicin
phyllanthu
emblica
xanthon
plant
swertiagenu
neohesperidin
hesperidin
citru
aurantium
exhibit
potenti
high
bind
affin
protein
howev
none
bind
compound
predict
target
interfac
addit
known
cut
spike
trigger
infect
sarscov
merscov
studi
shown
inhibit
enzym
activ
prevent
coronavirus
enter
host
cell
possibl
target
antivir
drug
discoveri
virtual
screen
result
shown
support
excel
file
predict
mani
antibacteri
drug
pivampicillin
hetacillin
cefoperazon
clindamycin
antiviru
natur
compound
phyllaemblicin
neoandrographolid
kouitchensid
etc
potenti
inhibitor
order
verifi
screen
result
zinc
drug
databas
util
current
resourc
antivir
drug
immedi
construct
databas
antivir
drug
deep
calcul
includ
compound
alreadi
market
current
undergo
clinic
trial
treat
infect
rdrp
inhibitor
bind
pocket
remdesivir
bottom
rna
templat
channel
posit
acceptor
templat
nucleotid
fig
b
compound
well
fit
shape
pocket
form
three
hydrogen
bond
addit
hydrophob
interact
may
direct
favorit
conform
remdesivir
fig
interestingli
remdesivir
predict
bind
target
low
bind
energi
score
mfscore
shown
fig
remdesivir
bound
rel
positivelycharg
alloster
pocket
far
away
enzym
activ
center
form
two
hydrogen
bond
phosphat
group
compound
weak
hydrophob
interact
pyrrolotriazin
ring
remdesivir
side
chain
polar
amino
acid
may
stabil
compound
conform
fig
also
perform
longitudin
analysi
drug
target
result
show
tenofovir
disoproxil
fumar
beclabuvir
may
bind
fewer
compound
predict
act
target
nrbd
crbd
show
select
antivir
drug
unlik
act
target
new
coronaviru
provid
meaning
refer
futur
research
target
complex
plpro
rdrp
helicas
echannel
spike
antivir
drug
predict
bind
especi
echannel
rdrp
plpro
indic
target
like
use
discoveri
therapeut
drug
known
antivir
focu
subsequ
research
ongo
epidem
make
us
pain
realiz
current
target
difficult
find
direct
inhibitor
nondrugg
target
like
echannel
etc
current
popular
protac
technolog
may
good
strategi
degrad
protein
inhibit
viru
potenti
bind
compound
found
studi
target
might
good
start
point
spike
protein
found
one
compound
natur
hesperidin
target
bind
spike
rbd
human
howev
like
bind
compound
noninterfac
bind
compound
may
still
meaning
applic
consid
fusion
cov
membran
host
cell
membran
need
big
conform
chang
remain
spike
part
rbd
remov
small
molecul
bound
spike
time
may
interfer
refold
spike
therefor
inhibit
viral
infect
process
furthermor
small
molecul
target
part
spike
protein
may
good
start
point
design
protac
base
therapi
also
dock
exist
antivir
drug
target
analyz
possibl
target
antivir
drug
horizont
analyz
drug
may
interact
target
vertic
analyz
target
base
dock
result
found
complex
plpro
rdrp
helicas
echannel
spike
like
therapeut
target
antivir
drug
three
target
echannel
screen
antivir
drug
may
due
model
problem
flexibl
small
protein
partial
model
echannel
whether
screen
antivir
drug
realli
work
target
need
verif
also
recommend
applic
new
coronaviru
pneumonia
compound
target
predict
triphosph
nucleotid
product
remdesivir
remdesivirtp
compet
rdrp
substrat
atp
interfer
viral
rna
synthesi
dock
result
show
remdesivirtp
bind
rdrp
score
dock
result
consist
origin
antivir
mechan
think
remdesivir
may
good
treat
pneumonia
addit
remdesivir
also
predict
bind
human
protein
facilit
viru
infect
new
discoveri
provid
idea
subsequ
research
chloroquin
phosphat
shown
better
effect
recent
studi
drug
clear
target
action
dock
result
chloroquin
phosphat
predict
possibl
combin
echannel
need
experi
verifi
conclus
